Blog

Can a light-based treatment called photobiomodulation help to treat degenerative brain diseases?

Michael VanElzakker, PhD, is a neuroscientist at Mass General who is using brain scans to learn more about chronic fatigue syndrome.

Even though we sleep so much of our life, we don’t know exactly what goes on in our brain when we sleep. But genetic studies can point a clear path for further investigation into the role of sleep.

Determined collaboration and groundbreaking technology have led to exciting advances in efforts to solve the challenges of brain diseases, researchers from the MassGeneral Institute for Neurodegenerative Diseases(MIND) told patients, families and friends recently. On May 16, 2018, nearly 100 people attended the event at the MIND labs at the Charlestown Navy Yard. MIND’s Visiting Day gatheringRead more

What’s new in research at Mass General? Here’s a snapshot of studies recently published in top-tier scientific journals: Effect of folic acid on child brain development Have you ever noticed that everything from cereal to pasta to pancake mix has folic acid listed as an ingredient?  This is due to a government-mandated folic acid fortificationRead more

A Mass General research team is investigating if boosting a specific brain activity during sleep can help treat learning and memory deficits in schizophrenia patients.

Here’s a quick look at some recent research studies from investigators at the Mass General Research Institute.

What’s new in research at Mass General? Here’s a snapshot of studies recently published in top-tier scientific journals.

When it comes to assessing the damage caused by natural disasters, experts often think in terms of primary and secondary effects. A primary effect of a flood, for example, would include the damage to homes and buildings caused by the rushing waters, while a secondary effect would be power outages resulting from downed trees andRead more

A new research study from Rudolph Tanzi, PhD, and Robert Moir, PhD, researchers in the Department of Neurology at Massachusetts General Hospital, has uncovered a Jekyll and Hyde role for a naturally occurring protein in the brain most commonly associated with Alzheimer’s disease (AD). In conjunction with new findings from another research team at Icahn School ofRead more